NASDAQ:MDXG MiMedx Group Q3 2026 Earnings Date & Estimates $4.43 -0.25 (-5.34%) Closing price 10/16/2026 04:00 PM EasternExtended Trading$4.43 0.00 (0.00%) As of 10/16/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. MiMedx Group is estimated to report Q3 2026 earnings on Wednesday, October 28, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateOctober 28, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from MiMedx Group in Q3 2026MiMedx Group is expected to post earnings of $0.0003 per share on revenue of $68.56 million. In the same quarter a year earlier MiMedx Group reported $0.15 per share on revenue of $113.73 million. MiMedx Group last reported on July 29, 2026, posting -$0.05 per share and missing the -$0.0495 consensus estimate. MiMedx Group has beaten the consensus EPS estimate in 5 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.0003Expected Revenue$68.56 millionPrior-Year EPS$0.15Prior-Year Revenue$113.73 millionExpected EPS Growth-99.8%Expected Revenue Growth-39.7%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.05 (Missed by -$0.0005)Last Quarter Revenue$64.36 millionEPS Beat Rate5 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report MiMedx Group Q3 2026 Earnings FAQ When does MiMedx Group report Q3 2026 earnings? MiMedx Group (NASDAQ:MDXG) is estimated to report Q3 2026 earnings on Wednesday, October 28, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is MiMedx Group's Q3 2026 earnings call? MiMedx Group's Q3 2026 earnings conference call is scheduled for Wednesday, October 28, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for MiMedx Group? Analysts expect MiMedx Group to post earnings of $0.0003 per share for Q3 2026. How much revenue is MiMedx Group expected to report? The consensus revenue estimate for MiMedx Group is $68.56 million for Q3 2026. MiMedx Group Earnings HeadlinesMiMedx-Sanara merger faces fresh regulatory obstacle – SMTI stock falls below this key support level for the first time in 4 monthsOctober 16 at 1:56 PM | msn.comMIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026October 14, 2026 | globenewswire.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets. | Weiss Ratings (Ad)Analysts Offer Insights on Healthcare Companies: Foghorn Therapeutics (FHTX) and MiMedx Group (MDXG)October 4, 2026 | theglobeandmail.comMIMEDX Announces Favorable Federal Court Ruling in AXIOFILL Regulatory Classification MatterSeptember 24, 2026 | marketscreener.comMMiMedx Group, Inc. Announces Favorable Federal Court Ruling In AXIOFILL Regulatory Classification MatterSeptember 24, 2026 | marketscreener.comMSee More MiMedx Group Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like MiMedx Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MiMedx Group and other key companies, straight to your email. Email Address About MiMedx GroupMiMedx Group (NASDAQ:MDXG). is a regenerative healthcare company that develops, manufactures and markets human placental tissue allografts and related biomaterial products. Its products are derived from donated human placental tissue and are processed for use in healthcare settings, including wound care, surgery and orthopedic applications. The company’s portfolio includes tissue allografts such as EPIFIX, EPIEFFECT, GRAFIX and AMNIOFIX. These products are designed to support the management of chronic and acute wounds, surgical reconstruction and other clinical procedures. MiMedx markets its products primarily to physicians, hospitals, wound-care centers and other healthcare providers. Founded in 2008 and headquartered in Marietta, Georgia, MiMedx serves customers primarily in the United States. The company focuses on research, development and commercialization of placental tissue technologies intended to support tissue repair and healing across a range of medical specialties.View MiMedx Group ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/12 - 10/16Bank of America Stock Sell-Off Looks Like a Buying OpportunityManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay SolidMorgan Stanley Beats on Earnings, But Shares Fall on Trading MixFundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?Palantir's Potential Next Catalyst After Retail Profit-TakingApple Cut iPhone 18 Orders; What Does It Mean For Suppliers? Upcoming Earnings America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026)GE Aerospace (10/20/2026)3M (10/20/2026)Northrop Grumman (10/20/2026)RTX (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
